ERCC1-Expression unter 5-FU- und Oxaliplatin-basierter multimodaler Therapie beim Rektumkarzinom (cUICC-Stadien II und III) - Potentielle prädiktive und prognostische Bedeutung

by Gauß, Korbinian Andreas
Published 2014

Role of ERCC1 expression in colorectal adenoma-carcinoma sequence and relation to other mismatch repair proteins expression, clinicopathological features and prognosis in mucinous...

by Abd AlRahman Mohammad Foda, Andrea Palicelli, Abdelhadi Shebl, Renzo Boldorini, Khaled Elnaghi, Amira K ElHawary
Published 2019-01-01

Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer

by Ying-Yi Chen, Yu-Jung Lin, Wei-Ting Huang, Chin-Chuan Hung, Hui-Yi Lin, Yu-Chen Tu, Dean-Mo Liu, Shou-Jen Lan, Ming-Jyh Sheu
Published 2018-12-01

Evaluation von ERCC1 als prädiktiver Biomarker bei mit platinbasierter Chemotherapie behandeltem Nebennierenrindenkarzinom

by Laufs, Valeria
Published 2019

Expression and Clinical Significance of ERCC1 and XPF in Human Hepatocellular Carcinoma

by Liao X, Li Y, Li H, Huang W, Wang H, Xie W
Published 2020-02-01

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers

by Tarek M. A. Abdel-Fatah, Reem Ali, Maaz Sadiq, Paul M. Moseley, Katia A. Mesquita, Graham Ball, Andrew R. Green, Emad A. Rakha, Stephen Y. T. Chan, Srinivasan Madhusudan
Published 2019-08-01

Association between Polymorphisms of ERCC1 and Response in Patients with Advanced Non-small Cell Lung Cancer Receiving Cisplatin-based Chemotherapy

by Yanfei GU, Xinjie YANG, Qunhui WANG, Hui ZHANG, Quan ZHANG, Jinghui WANG, Shucai ZHAN
Published 2010-04-01

RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin

by Wendy Muñoz-Montaño, Sae Muñiz-Hernández, Alejandro Avilés-Salas, Rodrigo Catalán, Luis Lara-Mejía, Suraj Samtani-Bassarmal, Andres F. Cardona, Jorge Mendoza-Desión, Daniel Hernández-Cueto, Altagracia Maldonado, Guillermina Baay-Guzmán, Sara Huerta-Yepes, Oscar Arrieta
Published 2021-08-01

Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

by Frank Jacobsen, Billurvan Taskin, Nathaniel Melling, Charlotte Sauer, Corinna Wittmer, Claudia Hube-Magg, Martina Kluth, Ronald Simon, Dirk Pehrke, Burkhard Beyer, Thomas Steuber, Imke Thederan, Guido Sauter, Thorsten Schlomm, Waldemar Wilczak, Katharina Möller, Sören A. Weidemann, Susanne Burdak-Rothkamm
Published 2017-07-01

Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study

by Marina Piljić Burazer, Suzana Mladinov, Antonela Matana, Sendi Kuret, Joško Bezić, Merica Glavina Durdov
Published 2019-09-01

Enhanced Cisplatin Cytotoxicity by RNA Interfering the Excision Repair Cross-complementing Gene 1 in Lung Cancer Cell A549/DDP

by Yun GAO, Dan SU, Lisha YING, Wangxia LV, Shenglin MA
Published 2010-09-01

The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients

by Hadeel Obiedat, Nasr Alrabadi, Eyad Sultan, Marwa Al Shatti, Malek Zihlif
Published 2018-07-01

Predictive value of KRAS mutation and excision repair cross-complementing 1 (ERCC1) protein overexpression in patients with colorectal cancer administered FOLFOX regimen

by Sun Min Park, Sung Bong Choi, Yoon Suk Lee, In Kyu Lee
Published 2021-05-01

The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer

by Rahul Sreekumar, Hajir Al‐Saihati, Muhammad Emaduddin, Karwan Moutasim, Massimiliano Mellone, Ashish Patel, Seval Kilic, Metin Cetin, Sule Erdemir, Marta Salgado Navio, Maria Antonette Lopez, Nathan Curtis, Tamer Yagci, John N. Primrose, Brendan D. Price, Geert Berx, Gareth J. Thomas, Eugene Tulchinsky, Alex Mirnezami, A. Emre Sayan
Published 2021-08-01

Role of Nucleotide Excision Repair in Cisplatin Resistance

by Mingrui Duan, Jenna Ulibarri, Ke Jian Liu, Peng Mao
Published 2020-12-01

Polymorphisms in DNA Repair Genes and Susceptibility to Glioma in a Chinese Population

by Jun-Hong Guan, Gang Li, Wei-Ran Pan
Published 2013-02-01

ERCC1 rs3212986 A/C polymorphism is not associated with chemotherapy treatment outcomes in gastric cancer patients: evidence from 11 publications in Chinese populations

by Tang WW, Wang H, Wang YM, Wang XW
Published 2017-12-01

The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer

by Song WH, Ma HS
Published 2016-06-01

ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis

by Yuqiang Zhang, Sufen Cao, Chunyu Zhuang, Jiacheng Chen, Xiaojing Chen, Hong Sun, Shengying Lin, Bailang Lin
Published 2021-06-01

Os genes ERCC1 e RRM1 no carcinoma broncopulmonar ERCC1 and RRM1 genes in lung cancer

by Lina Carvalho, António Silva, Cláudia Andrade, Cláudia Barroso, Cláudia Farinha, José Carlos Fernandes, Raquel Landeiro
Published 2009-08-01